← FDA DRUG APPROVALS

FDA ANDA · ANDA215641

CLOTRIMAZOLE

Sponsor: THINQ PHARM-CRO PVT

APPLICATION
ANDA215641
TYPE
ANDA
ORIGINAL APPROVAL
2024-02-29
LATEST ACTION
2024-02-29
ROUTE
ORAL
DOSAGE FORM
TROCHE/LOZENGE
MARKETING STATUS
Prescription

Products

CLOTRIMAZOLEPrescription
CLOTRIMAZOLE 10MG · TROCHE/LOZENGE · ORAL

Approval history

2024-02-29UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →